Angioblast Systems Report issue

For profit Phase 2
Founded: New York NY United States (2001)
Status: Acquired by Mesoblast, Inc. (2010)

Organization Overview

First Clinical Trial
2008
NCT00555828
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Heart Failure (Phase 2)

Infarction (Phase 2)

Myocardial Infarction (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2